Recall: D-0435-2023

Class II - Potentially Harmful

Class IIClassification

2023-02-28Initiated

TerminatedStatus

Sagent Pharmaceuticals IncFirm

Product

Heparin Sodium Injection, USP, 20,000 USP units per mL, 25 x 1 mL Multi-Dose Vials, Rx Only, For Intravenous or Subcutaneous Use, Mfd. for: Sagent Pharmaceuticals, Schaumburg, IL 60195; Made in India, NDC carton: 25021-404-01

Reason

Labeling: Not elsewhere classified

Distribution

USA Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.